Takeda Pharmaceutical Co., Ltd. (4502)

Tokyo


Symbol		Exchange		Currency
4502	·	Tokyo	·	JPY	Delayed
TAK	·	NYSE	·	USD	Real-time
TKPHF	·	OTC Markets	·	USD	Delayed
4502	·	Frankfurt	·	EUR	Delayed
4502	·	TradeGate	·	EUR	Delayed
TAKP34	·	B3	·	BRL	Delayed
TKD	·	Vienna	·	EUR	Real-time

Currency in JPY

4,296.0

+10.0(+0.23%)

Closed·07:30:29

Fair Value

Unlock Value

Day's Range

4,258.0

4,297.0

52 wk Range

3,852.0

4,573.0

4502 Income Statement

Featured here, the Income Statement (earnings report) for Takeda Pharmaceutical Co., Ltd., showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Period Ending:

2016

31/03

2017

31/03

2018

31/03

2019

31/03

2020

31/03

2021

31/03

2022

31/03

2023

31/03

2024

31/03

2025

31/03

Total Revenues

aa.aa

3,197,812

3,569,006

4,027,478

4,263,762

4,581,551

Total Revenues Growth

aa.aa

-2.84%

+11.61%

+12.85%

+5.87%

+7.45%

Cost Of Revenues

aa.aa

1,013,655

1,127,308

1,253,163

1,431,505

1,571,419

Gross Profit

aa.aa

2,184,157

2,441,698

2,774,315

2,832,257

3,010,132

Gross Profit Growth

aa.aa

+0.6%

+11.79%

+13.62%

+2.09%

+6.28%

Gross Profit Margin %

aa.aa

68.3%

68.41%

68.88%

66.43%

65.7%

Other Operating Expenses, Total

aa.aa

1,760,110

1,841,636

2,154,648

2,332,782

2,447,196

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-6.1%	+4.63%	+17%	+8.27%	+4.9%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	455,765	526,087	633,325	728,617	730,226
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	875,514	886,327	997,234	1,053,819	1,104,732
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	23,602	10,433	38,987	28,821	64,052

Operating Income

aa.aa

424,047

600,062

619,667

499,475

562,936

Operating Income Growth

aa.aa

+42.93%

+41.51%

+3.27%

-19.4%

+12.71%

EBIT Margin %

aa.aa

13.26%

16.81%

15.39%

11.71%

12.29%

Net Interest Expenses

aa.aa

-128,653

-117,669

-111,192

-103,764

-110,504

Net Interest Expenses Growth

aa.aa

+5.65%

+8.54%

+5.5%

+6.68%

-6.5%

Interest Expense, Total

aa.aa

-130,806

-122,432

-116,973

-115,392

-130,487

Interest And Investment Income

aa.aa

2,153

4,763

5,781

11,628

19,983

Other Non Operating Expenses, Total

aa.aa

-14,381

-45,389

-14,384

-38,659

-28,065

EBT, Excl. Unusual Items

aa.aa

281,013

437,004

494,091

357,052

424,367

Gain (Loss) On Sale Of Assets

aa.aa

235,117

8,164

8,901

7,975

10,561

Other Unusual Items, Total

aa.aa

-34,020

-67,243

-91,084

-230,878

-112,826

EBT, Incl. Unusual Items

aa.aa

366,235

302,571

375,090

52,791

175,084

EBT, Incl. Unusual Items Growth

aa.aa

+702.82%

-17.38%

+23.97%

-85.93%

+231.66%

EBT, Incl. Unusual Items Margin

aa.aa

11.45%

8.48%

9.31%

1.24%

3.82%

Income Tax Expense

aa.aa

-9,936

72,405

58,052

-91,406

66,941

Net Income to Company

aa.aa

376,171

230,166

317,038

144,197

108,143

Minority Interest

aa.aa

-166

-107

-21

-130

-215

Net Income

aa.aa

376,005

230,059

317,017

144,067

107,928

Net Income Growth

aa.aa

+749.9%

-38.81%

+37.8%

-54.56%

-25.08%

Net Income Margin %

aa.aa

11.76%

6.45%

7.87%

3.38%

2.36%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

376,005

230,059

317,017

144,067

107,928

Basic EPS - Continuing Operations

aa.aa

240.72

147.14

204.29

92.09

68.36

Basic EPS - Continuing Operations Growth

aa.aa

+747.29%

-38.87%

+38.84%

-54.92%

-25.77%

Diluted EPS - Continuing Operations

aa.aa

238.96

145.87

201.94

91.16

67.23

Diluted EPS - Continuing Operations Growth

aa.aa

+745.88%

-38.96%

+38.44%

-54.86%

-26.25%

Basic Weighted Average Shares Outstanding

aa.aa

1,562.01

1,563.5

1,551.81

1,564.45

1,578.87

Diluted Weighted Average Shares Outstanding

aa.aa

1,573.54

1,577.17

1,569.87

1,580.34

1,605.32

Dividend Per Share

aa.aa

180

188

196

Dividend Per Share Growth

aa.aa

+4.44%

+4.26%

EBITDA

aa.aa

983,718

1,183,213

1,284,067

1,143,936

1,233,262

EBITDA Growth

aa.aa

+11.74%

+20.28%

+8.52%

-10.91%

+7.81%

EBITDA Margin %

aa.aa

30.76%

33.15%

31.88%

26.83%

26.92%

EBIT

aa.aa

424,047

600,062

619,667

499,475

562,936

* In Millions of JPY (except for per share items)

NSE 30

5,103.27

+44.13

+0.87%

NSE All Share

139,114.69

+1,201.81

+0.87%

US 30

44,667.80

+34.8

+0.08%

US 500

6,381.60

+10.7

+0.17%

FTSE 100

9,112.65

-23.67

-0.26%

DAX

24,243.90

+45.62

+0.19%

South Africa Top 40

91,560.27

+39.53

+0.04%

Market Movers

Name	Last	Chg. %	Vol.
Fidelitybk	21.500	+4.88%	77.10M
Guaranty Trust Holding	101.90	+3.98%	11.70M
Nascon	99.90	+8.59%	9.66M
Lafarge Africa	150.80	+7.48%	7.44M
MTN Nigeria	485.00	+7.40%	4.74M
Dangote Cement	516.00	+1.26%	2.16M
Aradel Holdings	514.10	+0.23%	1.32M

Name	Last	Chg. %	Vol.
Union Dicon Salt	9.90	+10.00%	61.70K
SCOA Nigeria	5.500	+10.00%	55.47K
Airtel Africa	2,541.50	+10.00%	53.00
Custodian Allied	36.30	+10.00%	94.51K
Berger Paints	37.50	+9.97%	1.33M
Guinness Nigeria	117.05	+9.96%	11.75K
Academy Press	12.38	+9.95%	424.65K

Name	Last	Chg. %	Vol.
Transcorp Power	288.00	-10.00%	18.09K
Abctrans	4.81	-3.80%	905.59K
Total Nig	634.50	-10.00%	97.30K
Abbey Mortgage Bank	6.48	-10.00%	194.93K
Geregu Power	1,027.40	-10.00%	865.00
Nahco	105.300	-10.00%	2.31M
FTN Cocoa Processors PLC	6.30	-10.00%	7.30M

Trending Stocks

Name	Last	Chg. %	Vol.
MTN Nigeria	485.00	+7.40%	4.74M
Aradel Holdings	514.10	+0.23%	1.32M
Access Holdings	27.80	+2.21%	6.18M
Initiates	14.90	-1.32%	2.83M
VFD PLC	13.90	-0.71%	4.02M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aa Aaaaaaaa	5,310.00	+34.49%	7,141.42
Aaaaaaaaa	66.50	+28.35%	85.35
Aaa Aa	516.00	+27.29%	656.82
Aaaaaaaaaaa	124.00	+22.72%	152.17

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers

Popular Searches

Please try another search

Takeda Pharmaceutical Co., Ltd. (4502)

4502 Income Statement

Trending Stocks